Hunziker, F. published the artcileChemistry and pharmacology of dibenzo[b,e][1,4]diazepine derivatives with basic substituents in position 10, Quality Control of 60091-87-4, the publication is Arzneimittel-Forschung (1963), 324-8, database is CAplus and MEDLINE.
A series of I derivatives was prepared according to Clemo, et al. (CA 19, 293) and Burton and Gibson (CA 19, 987) by an Ullmann-synthesis from o-bromonitrobenzenes and free anthranilic acid derivatives in presence of K2CO3 and catalytic amounts of Cu in a higher alcohol as solvent. The N-methylated anthranilic acids gave lower yields (50-60%) than the corresponding primary amines. The esters of I were best obtained via the acid chlorides. Thus, the following I derivatives were prepared (R1, R2, R3, and m.p. given): H, 4-Me, H, 213-15°; H, 4-Me, Et, 99-100°; Me, 4-Me, H, 140-1°; H, 4-Cl, H, 245-8°; H, 4-Cl, Et, 134-6°; Me, 4-Cl, H, 139-42°; H, 4-CF3, H, 225-6°; H, 4-CF3, Me, 147-8°; Me, 4-CF3, H, 154-6°; H, 4-OMe, H, 228-30°; H, OMe, Et, 104°; Me, 4-OMe, H, 164-6°; H, 5-Cl, Me, 157-8°; H, 5-Cl, Et, 127-8°; Me, 5-Cl, H, 160°; Me, 5-Cl, Me, 92-3°; H, 5-OMe, Me, 149°; H, 5-SMe, Et, 187-8°; Me, 5-SMe, Me, 102-3°; H, 6-Cl, Me, 119-20°; H, 5′-Cl, Et, 106-7°; H, 5′-OMe, H, 235-7°; H, 4′-Cl, H, 232-5°; H, 4′-Cl, Me, 138°; H, 4′-OMe, H, 240°; Me, 4′-OMe, H, 168-72°. To a cooled solution of 5.9 g. K in 110 ml. tert-BuOH was added under stirring 12 g. MeSH. At 20°, a solution of 40.3 g. I (R1 = R3 = Me, R2 = 5-Cl) in 300 ml. HCONMe2 was added. After 2 hrs. stirring at 80°, evaporation to dryness in vacuo, distribution between benzene and NaHCO3 solution, evaporation of the benzene, and crystallization from Et2O/petr. ether gave 40 g. I (R1 = R3 = Me, R2 = 5-SMe), m. 102-3°. To 135.6 g. I (R1 = R3 = H, R2 = 5-Cl) 10.3, suspended in 1.8 l. 2N aqueous NH3 was added within 3 hrs. 266 g. Na2S2O4. The mixture was heated to 80° till solution was complete. Charcoal treatment, acidification to pH 4.5 with AcOH, addition of NaCl, and work-up gave 121.3 g. II (R1 = R3 = H, R2 = 5-Cl), m. 208-5° (decomposition) (MeOH-H2O). Similarly prepared were the II derivatives (R1, R2, R3, m.p. given): H, 4-Me, H, 213-15°; Me, 4-Me, H, 144-6°; H, 4-Cl, H, 200-5°; Me, 4-Cl, H, 155°; H, 4-CF3, H, 214-15°; Me, 4-CF3, H, 160°; H, 4-OMe, H, 200°; Me, 4-OMe, H, 132-4°; H, 5-Cl, Me, 117-18°; Me, 5-Cl, H, 155°; H, 5-OMe, H, 178-9°; H, 5-SMe, H, 170-2°; H, 6-Cl, Me, 135-9°; H, 5′-Cl, H, 175-7°; H, 5′-OMe, H, 182-4°; H, 4′-Cl, H, 197-8°. II (R1 = R3 = H, R2 = 5-Cl) (121.3 g.) was refluxed in 3 l. xylene 40 hrs. under continuous removal of H2O. After distillation of the solvent and vapor distillation for removal of impurities, the residue was made alkaline with dilute NH3, filtered, treated with charcoal, and crystallized from Me2CO-H2O to give 71.3 g. III (R1 = H, R2 = 7-Cl), m. 253-4°. The same compound was also obtained by refluxing of 2.5 g. II (R1 = H, R2 = 5-Cl, R3 = Me) with 0.39 g. NaNH2 in 20 ml. dioxane, dilution with H2O, and filtration in 83% yield. Similarly prepared were the following III derivatives (R1, R2, m.p. given): H, 2-Cl, 259-60°; H, 2-OMe, 220-1°; Me, 2-OMe, 200-12°; H, 3-Cl, 271°; H, 3-OMe, 232-3°; H, 3-Me, 267-9°; H, 6-Cl, 244-6°; Me, 7-Cl, 226-7°; H, 7-OMe, 239-40°; H, 7-SMe, 211-12°; Me, 7-SMe, 225-6°; H, 8-Cl, 231-2°; Me, 8-Cl, 214-15°; H, 8-Me, 194-5°; Me, 8-Me, 228-9°; H, 8-CF3, 176-7°; Me, 8-CF3, 239-40°; H, 8-OMe, 174-6°; Me, 8-OMe, 221-3°. III (R1 = H, R2 = 7-Cl) (52.5 g.) was refluxed 1 hr. with 9.2 g. NaNH2 in 350 ml. dioxane, then 29 g. ClCH2CH2NMe2 in 50 ml. benzene was added and the mixture refluxed 16 hrs. Concentration in vacuo, distribution between benzene/H2O, extraction of the benzene with diluted HCl, alkalinization of the extract with NH3, extraction with CHCl3, evaporation of the solvent, and crystallization from Me2CO/Et2O gave 50.8 g. IV (R1 = H, R2 = 7-Cl), m. 165-6°, ε230 32,740 (EtOH); hydrochloride m. 225-33° (EtOH-Et2O). The same compound was obtained by refluxing 11.4 g. II (R1 = H, R2 = 5-Cl, R3 = Me) 90 min. with 1.8 g. NaNH2 in 90 ml. dioxane, then adding 6 g. ClCH2CH2NMe2 in 20 ml. benzene, and refluxing 15 hrs. (and usual work-up) in 56% yield. Similarly prepared were the following IV derivatives (R1 R2, m.p. free base, m.p. hydrochloride, L.D.59 mg./kg. mouse per os given): H, H, 112-14°, -, 705; Me, H, 116-17°, 234-40°, 215; H, 2-Cl, 172-3°, -, 175; Me, 2-OMe, -, 205-10°, 900; H, 3-Cl, 159-60°, -, 305; H, 3-OMe, 141-3°, -, 150; H, 6-Cl, 122-3°, -, 260; H, 7-Cl, 165-6°, 225-33°, 330; Me, 7-Cl, -, 247-53°, 500; H, 7-OMe, 152-3°, -, 220; H, 7-SMe, 126-9°, -, 345; Me, 7-SMe, -, 205-7°, 520; H, 8-Cl, 140-5°, -, -; Me, 8-Cl, -, 240-5°, 500; H, 8-OMe, 126-7°, -, 220; H, 8-CF3, 115-18°, -, 150; Me, 8-CF8, -, 222-6°, 240; H, 8-Me, 137-8°, -, 127; Me, 8-Me, -, 214-17°, 100. Also prepared were the V derivatives (X, m.p., D.L.50 mg./kg. mouse per os given): 2-pyrrolidinoethyl, 159-60°, 700; 2-piperidinoethyl, 187-9°, 700; 2-morpholinoethyl, 220-2°, >2500; CH2CHMeNMe2, 197-9°, 320; (CH2)3NMe2, 137-9°, 1000. Reduction of the corresponding oxo derivatives with LiAlH4 in tetrahydrofuran gave the VI derivatives (R1, R2, m.p., L.D.50 mg./kg. mouse per os given): H, H, (maleate m. 100°), 600; Me, H, – (maleate m. 149-51°), 760; H, Cl, 87-9°, 275. IV (R1 = H, R2 = 2-Cl) (20 g.) was refluxed 24 hrs. in 200 ml. 5N HCl. Concentration in vacuo, addition of NaOH, and isolation of the resulting base gave 14.8 g. VII, b8.97 130-8°. Acetylation with Ac2O in pyridine gave VIII, m. 109-11°. To prove the structure, VIII was also synthesized independently. Thus, IX was acetylated to give X, m. 89-90° (Et2O-petr. ether). X (31 g.) was alkylated with 4 g. NaNH2 and 9.5 g. ClCH2CH2NMe2 in 150 ml. dioxane to give after usual work-up 31.5 g. VIII. To test the influence of the N bridge on the pharmacol. properties, XI was prepared by refluxing 11.7 g. phenanthridone with 2.95 g. NaNH2 in 120 ml. dioxane for 2 hrs. Addition of 7 g. ClCH2CH2NMe2 in 50 ml. dioxane during 4 hrs., refluxing for 10 hrs, and normal work-up gave XI; hydrochloride m. 268-70° (MeOH-Et2O). The XII derivatives were also prepared (X, m.p., L.D.50 mg./kg. mouse per os given): S, 268-71° (hydrochloride) 870; SO2, 113-23°, 620; O, 230-3° (hydrochloride), 500. The influence of the chem. constitution on the pharmacological activity was studied. A heterocyclic bridge in position 5 is indispensable for activity; derivatives of benzanilide and phenanthridone having basic substituents are inactive. An unsubstituted NH-group in position 5 has a more favorable effect than the Me-substituted N and is superior in activity to other hetero-bridges such as SO2, S, and O. Compounds with substituents in position 7 show greater activity than the unsubstituted compound A carbonyl group in position 11 is essential for activity, the corresponding VI derivatives, although closely related to known antihistamines of the benzylaniline group are practically inactive in vivo. In agreement with other classes of antihistamines, the (CH2)2NMe2 and (CH2)3NMe2 groups are the most effective basic substituents. IV (R1 = H, R2 = 7-Cl) and the corresponding 7-SMe derivative belong to the most potent antihistaminics of today.
Arzneimittel-Forschung published new progress about 60091-87-4. 60091-87-4 belongs to chlorides-buliding-blocks, auxiliary class Chloride,Nitro Compound,Carboxylic acid,Amine,Benzene, name is 2-((4-Chloro-2-nitrophenyl)amino)benzoic acid, and the molecular formula is C13H9ClN2O4, Quality Control of 60091-87-4.
Referemce:
https://en.wikipedia.org/wiki/Chloride,
Chlorides – an overview | ScienceDirect Topics